https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-05-31 / Int Immunopharmacol 2024 Jul;136:112305
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-05-31 / Int Immunopharmacol 2024 Jul;136:1123052024-05-31 00:00:002024-05-31 00:00:00Oncolytic Newcastle disease virus carrying the IL24 gene exerts antitumor effects by inhibiting tumor growth and vascular sprouting
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-05-30 / Viruses 2024 May;16(6)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-05-30 / Viruses 2024 May;16(6)2024-05-30 00:00:002024-05-30 00:00:00The Application of Newcastle Disease Virus (NDV): Vaccine Vectors and Tumor Therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-04-09 / Med Oncol 2024 Apr;41(5):112
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-04-09 / Med Oncol 2024 Apr;41(5):1122024-04-09 00:00:002024-04-09 00:00:00Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-03-21 / Front Immunol 2024;15:1375433
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-03-21 / Front Immunol 2024;15:13754332024-03-21 00:00:002024-03-21 00:00:00New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-02-01 / Cancer Lett 2024 Mar;585:216634
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-02-01 / Cancer Lett 2024 Mar;585:2166342024-02-01 00:00:002024-02-01 00:00:00Oncolytic virus-based combination therapy in breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-10-19 / Methods Cell Biol 2024;183:51-113
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-10-19 / Methods Cell Biol 2024;183:51-1132023-10-19 00:00:002024-04-20 10:47:17Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-07-31 / Cancers (Basel) 2023 Jul;15(15)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-07-31 / Cancers (Basel) 2023 Jul;15(15)2023-07-31 00:00:002023-07-31 00:00:00Clinical Applications of Immunotherapy for Recurrent Glioblastoma in Adults
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-07-26 / Life (Basel) 2023 Jul;13(8)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-07-26 / Life (Basel) 2023 Jul;13(8)2023-07-26 00:00:002023-07-26 00:00:00The Viral Knock: Ameliorating Cancer Treatment with Oncolytic Newcastle Disease Virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-07-07 / Neurooncol Adv 2023;5(1):vdad081
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-07-07 / Neurooncol Adv 2023;5(1):vdad0812023-07-07 00:00:002023-07-07 00:00:00Recent oncolytic virotherapy clinical trials outline a roadmap for the treatment of high-grade glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-04-10 / Genes (Basel) 2023 Apr;14(4)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-04-10 / Genes (Basel) 2023 Apr;14(4)2023-04-10 00:00:002023-04-10 00:00:00Transcriptome Analysis of Natural Killer Cells in Response to Newcastle Disease Virus Infected Hepatocellular Carcinoma Cells
